About Clinpal
Clinpal is a Healthcare company based in Stirling (United Kingdom) founded in 2012, and was acquired by Cambridge Cognition in October 2022. Technology and consulting for clinical trials industry are provided. Clinpal has raised $3.37 million across 1 funding round from investors including Cambridge Cognition, 3wVentures and Verve Ventures. The company has 11 employees. Its chief executive, as recorded, is Karl Landert. Clinpal offers products and services including CANTAB, Voice Analysis, Electronic Questionnaires, High Frequency Testing, and Decentralised Clinical Trials. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Clinical Trials. Its legal entity is ECLINICALHEALTH LTD.
Company details
eClinicalHealth are a technology and consulting company providing solutions for the clinical trials industry. The company has developed a technology solution called Clinpal: Clinpal is a patient-centric, cloud-enabled platform that improves patient engagement and data acquisition through every step of the clinical trial journey. Clinpal allows clinical trials get closer to the patient, improving trial efficiency, patient retention and helps capture high quality data in real time. The platform features a comprehensive workflow and communication engine for all stakeholders, including sites, patients CRAs and sponsors, which improves efficiency through the trial lifecycle. Clinpals data exchange capabilities enable the platform to act as an intelligent data hub, consolidating and enhancing biometric data with eSource reported directly by patients or clinicians. The scalable cloud architecture, automated configuration and flexible licensing models make these capabilities a viable choice across a wide range of clinical trials.
- Headquarters Stirling, United Kingdom
- Employees 11
- Stage Acquired
- SectorsHealthcare
- Website clinpal.com
- Social LinkedIn
- Acquired by Cambridge Cognition (Oct 2022)
- Legal Name Eclinicalhealth Ltd
- Date of Incorporation 06 Feb, 2012
- Jurisdiction GLASGOW, SCOTLAND
- Total Equity Funding$3.37M (USD)
in 1 rounds
- Latest Funding Round$3.37M (USD), Series C
Sep 2014
- InvestorsCambridge Cognition
& 2 more
- Employee Count11
- Acquired byCambridge Cognition
(Oct 2022)
Products & Services of Clinpal
Clinpal offers a comprehensive portfolio of products and services, including CANTAB, Voice Analysis, Electronic Questionnaires, High Frequency Testing, and Decentralised Clinical Trials.
Software for sensitive cognitive evaluations in clinical research.
Technology for verbal cognitive assessments in health studies.
Digital tools for administering health and cognitive scales.
Tasks for regular cognitive function tracking in trials.
End-to-end system for remote trial management and data collection.
Funding Insights of Clinpal
Clinpal has successfully raised a total of $3.37M through 1 strategic funding round. The most recent funding activity was a Series C round of $3.37 million completed in September 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $3.37M
- Total Rounds 1
- Last Round Series C — $3.37M
- First Round $3.37M
(Sep 2014)
- Investors Count 2
All 1 funding rounds of Clinpal with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2014 | $3.37M | Series C | – | 3wVentures, Verve Ventures | – |
3 investors in total: 3 institutional.
Investors in Clinpal
Clinpal has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Cambridge Cognition, 3wVentures and Verve Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| 3wventures.com | ||||
Venture capital firm focused on science and tech-driven startups | verve.vc | Berlin, Germany | ||
Computerized neuropsychological tests are offered for cognitive assessment. | 2002 | cambridgecognition.com | Cambridge, United Kingdom |
Investor details for Clinpal
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Clinpal
1 people are tracked at Clinpal (1 in leadership); the tracked headcount is 11.
| Name | Role | Group |
|---|---|---|
Karl Landert | CEO | Leadership |
Complete people profiles for Clinpal
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Clinpal
3 dated milestones of Clinpal across 10 years, from founding to its latest funding, stage changes and deals.
- Founded Clinpal is founded.
- Funding First funding round of $3.4M.
- Exit Acquired by Cambridge Cognition.
Web traffic of Clinpal
Websites that share an audience with Clinpal (clinpal.com).
Websites whose visitors overlap most with Clinpal. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| excointouch.com | 68% | View details |
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Clinpal (Life Sciences Platforms & Tools) in United Kingdom, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | |||
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Clinpal
Complete news archive for Clinpal
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Clinpal
Clinpal was founded in 2012 and raised its 1st funding round 2 years after it was founded.
Clinpal is headquartered in Stirling, United Kingdom. It is registered at Stirling, Scotland, United Kingdom.
Karl Landert is the CEO of Clinpal, as recorded in our data.
Clinpal is a funded company, having raised a total of $3.37M across 1 funding round to date. The company's 1st funding round was a Series C of $3.37M, raised on Sep 2014.
Clinpal has 11 employees.
eClinicalHealth are a technology and consulting company providing solutions for the clinical trials industry. The company has developed a technology solution called Clinpal: Clinpal is a patient-centric, cloud-enabled platform that improves patient engagement and data acquisition through every step of the clinical trial journey. Clinpal allows clinical trials get closer to the patient, improving trial efficiency, patient retention and helps capture high quality data in real time. The platform features a comprehensive workflow and communication engine for all stakeholders, including sites, patients CRAs and sponsors, which improves efficiency through the trial lifecycle. Clinpals data exchange capabilities enable the platform to act as an intelligent data hub, consolidating and enhancing biometric data with eSource reported directly by patients or clinicians. The scalable cloud architecture, automated configuration and flexible licensing models make these capabilities a viable choice across a wide range of clinical trials.
Clinpal offers CANTAB, Voice Analysis, Electronic Questionnaires, High Frequency Testing, and Decentralised Clinical Trials.
Clinpal has 3 investors. Key investors include Cambridge Cognition, 3wVentures, and Verve Ventures.
Clinpal operates through Eclinicalhealth Ltd.
Yes. Clinpal was acquired by Cambridge Cognition in October 2022.